Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Video library· ARTC-Dr. Max MacCloudAudio: English

Retatrutide Warning: Don't Lose Muscle While Losing Fat

Thumbnail from YouTube. Playing loads the YouTube player.

History & recommendationsOff

Keep recently viewed content on this browser. Your history stays on this device and is never sent to Harbor. Videos you play can also help order related video recommendations.

Up to 120 items · 90 days. Turning this off deletes the history.
Open saved items & history →

About this video

Creator description · original textText language: English

Are weight loss drugs destroying your muscle mass? Learn why relying on semaglutide without a plan can lead to dangerous depletion. Many people focus only on the scale, but losing 21 pounds of muscle mass is a serious metabolic setback. This breakdown examines the real impact of weight loss drugs like semaglutide and tirzepatide on your body composition. We use the case of a 52-year-old executive to demonstrate how these medications can act as an arsonist in your metabolic kitchen if not managed correctly. If you are currently taking or considering these treatments, understanding the physiological risks is essential for long-term health. We discuss the exact protocol needed when using retatrutide to avoid becoming a sentient bag of pudding. By prioritizing muscle retention, you can protect your metabolic health while managing your weight effectively.

ARTC-Dr. Max MacCloud · 12 min · Source published: 2026-08-05

Added to Harbor: 10/23/2026

Original on YouTube ↗

Automatically categorized source. Creator statements are not an independent evidence review or personal medical guidance.

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…